Tag: AbbVie Inc.

Biologic Therapeutics Market to Hit $794.5 Billion by 2029

"Driven by Rising Chronic Disease Burden and Breakthrough FDA Approvals, Biopharmaceutical Market Surges with Demand for Monoclonal Antibodies, Gene and Cell Therapies, and Innovative...

Biologic Therapeutics Market to Hit $794.5 Billion by 2029

"Driven by Rising Chronic Disease Burden and Breakthrough FDA Approvals, Biopharmaceutical Market Surges with Demand for Monoclonal Antibodies, Gene and Cell Therapies, and Innovative...

Refresh Releases First of its Kind Eye Drop for Dry Eyes

Refresh Advanced OMEGA-3 Lubricant Eye Drops are the first eye drops on the market with omega-3 fatty acids MONTREAL, July 11, 2025 /CNW/ - AbbVie...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsAbbVie Inc.

Bandwidth Announces Kimberly McLachlan as Chief Revenue Officer

10th Huawei ICT Competition Concludes with Student Winners from 49 Countries and Regions and a Record 220,000 Participants

Selagine Plasma to Advance Pooled Plasma Eye Drops for Moderate-to-Severe Dry Eye

Tag: AbbVie Inc.

Biologic Therapeutics Market to Hit $794.5 Billion by 2029

Biologic Therapeutics Market to Hit $794.5 Billion by 2029

Refresh Releases First of its Kind Eye Drop for Dry Eyes

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us